RTOG 9804: A prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation

Journal of Clinical Oncology

Volumn 33, Issue 7, 2015, Pages 709-715

  McCormick, Beryl ^a   Winter, Kathryn ^b   Hudis, Clifford ^a   Kuerer, Henry Mark ^e   Rakovitch, Eileen ^p   Smith, Barbara L ^f   Sneige, Nour ^e   Moughan, Jennifer ^b   Shah, Amit ^c   Germain, Isabelle ^q   Hartford, Alan C ^g   Rashtian, Afshin ^h   Walker, Eleanor M ^j   Yuen, Albert ^d   Strom, Eric A ^e   Wilcox, Jeannette L ^k   Vallow, Laura A ^l   Small, William ^m   Pu, Anthony T ⁱ   Kerlin, Kevin ⁿ   White, Julia ^o   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Statistics   (United States)

^c York Cancer Center   (United Kingdom)

^d READING HOSPITAL AND MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Radiological Associates of Sacramento Medical Group Inc   (United States)

^j HENRY FORD HOSPITAL   (United States)

^k Greenville Community Clinical Oncology Program   (United States)

^l MAYO CLINIC   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ Southeast Cancer Control Consortium   (United States)

^o OHIO STATE UNIVERSITY   (United States)

^p DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^q LAVAL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ACUTE TOXICITY; ADULT; ARTICLE; BREAST CANCER; CANADA; CANCER RADIOTHERAPY; CANCER RISK; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES; ADJUVANT RADIOTHERAPY; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MANAGEMENT; MAMMOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PREVENTION AND CONTROL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE; WATCHFUL WAITING;

ADULT; AGED; BREAST NEOPLASMS; CANADA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE MANAGEMENT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; WATCHFUL WAITING;

EID: 84924616285     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.57.9029     Document Type: Article

References (26)

1. Siegel R, NaishadhamD, Jemal A: Cancer statistics 2013. CA Cancer J Clin 63:11-30, 2013
2. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
3. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med347:1227-1232, 2002
4. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998
5. Julien JP, Bijker N, Fentimen IS, et al: Radiotherapy in breast conserving treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10853-EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528-533, 2000
6. Emdin SO, Granstrand B, Ringberg A, et al: SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast-Results of a randomized trial in a population offered mammography screening. Acta Oncol 45:536-543, 2006
7. Houghton J, George WD, Cuzick J, et al: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia and New Zealand: Randomized controlled trial. Lancet 362:95-102, 2003
8. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455-1461, 1999
9. Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
10. The Consensus Conference Committee: Consensus Conference on the classification of ductal carcinoma in situ. Cancer 80:1798-1802, 1997
11. Lester SC, Connolly JL, Amin MB: College of American Pathologists protocol for the reporting of ductal carcinoma in situ. Arch Pathol Lab Med 133:13-14, 2009
12. Woodward W, Sneige N, Winter K, et al: Web based pathology assessment in RTOG 98-04. J Clin Pathol 67:777-780, 2014
13. Lagios MD, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618-624, 1989
14. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999
15. Zelen M: The randomization and stratification of patients to clinical trials. J Chronic Dis 27:365-375, 1974
16. Kim K, Tsiatis AA: Study duration for clinical trials with survival response and early stopping rule. Biometrics 46:81-92, 1990
17. Kalbfleisch J, Prentice R: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley & Sons, 1980, pp 167-169
18. Kaplan EL, Meier P: Nonparameteric estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958
19. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
20. Gray R: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
21. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
22. Hughes LL, Wang M, Page DL, et al: Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319-5324, 2009
23. Wong JS, Chen YH, Gadd MA, et al: Eightyear update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 143:343-350, 2014
24. Cuzick J, Sestak I, Pinder SE, et al: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29, 2011
25. Early Breast Cancer Trialists' Collaborative Group, Correa C, McGale P, et al: Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162-177, 2010
26. Solin LJ, Kurtz J, Fourquet A, et al: Fifteenyear results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754-763, 1996